ECE-1 (Recombinant)
- Expression system
- HEK293
- Cat. #
- REC-ECE1
In stock
- SKU
- REC-ECE1
Target Overview
ECE-1 (Endothelin-converting enzyme 1; UniProt P42892; EC 3.4.24.71) is a type II transmembrane zinc metalloprotease of 770 amino acids that cleaves the Trp21–Val22 bond of big endothelin-1, generating the biologically active 21-residue peptide endothelin-1 (ET-1). It is localised at the cell membrane and is a member of the neprilysin (M13) family of neutral endopeptidases. This recombinant is produced in HEK293 cells, providing mammalian glycosylation that is relevant to the native enzyme's folding and catalytic integrity. HEK293-derived ECE-1 retains the zinc-dependent metalloprotease active site and is suitable for direct use in fluorogenic or HPLC-based big endothelin-1 cleavage assays without refolding steps. In the laboratory, this recombinant protein serves several distinct purposes. Enzymologists use it to measure ECE-1 kinetic parameters (Km, kcat) against big endothelin-1 substrates and to determine IC50 values for phosphoramidon-class and small-molecule metalloprotease inhibitors. It is also used in substrate-profiling experiments that employ mass spectrometry to characterise the enzyme's broader peptide-bond selectivity. Because the protein is produced in a well-characterised mammalian system at consistent purity, it functions as a reliable positive control antigen for antibody validation by Western blot and ELISA. Researchers requiring an antibody reagent alongside this recombinant can pair it with the Triple Point Biologics matched antibody (SKU: RP-ECE1), which has been validated for Western blot against human ECE-1. The recombinant protein provides a defined positive-control standard for confirming antibody specificity and for titrating detection sensitivity in those assay formats.
Background
Applications
- Big endothelin-1 cleavage activity assay (fluorogenic or HPLC readout)
- Metalloprotease inhibitor IC50 determination (e.g., phosphoramidon analogues, small-molecule candidates)
- Kinetic parameter measurement (Km, kcat) against synthetic peptide substrates
- Substrate-scope profiling by mass spectrometry to map ECE-1 peptide-bond selectivity
- Co-immunoprecipitation or pull-down to study ECE-1 protein–protein interactions (e.g., ACTB, ROCK2 axis)
- Western blot positive-control antigen for anti-ECE-1 antibody validation (pair with RP-ECE1)
- ELISA capture/standard to calibrate anti-ECE-1 antibody sensitivity and dynamic range
- Comparative amyloid-beta degradation assay alongside neprilysin and IDE
References
- Wang L et al. ECE1c promotes glioblastoma invasion via the ROCK2-MYH10 axis and interaction with ACTB. Am J Transl Res. 2026. doi:10.62347/SQBU5335 PMID: 42007117
Additional Specifications
| Storage Buffer | 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol |
|---|---|
| Endotoxin Level | <0.1 EU/µg by LAL |
| Purity (%) | >90% by SDS-PAGE |
| Expression System | HEK293 |
| Subcellular Localization | Subcellular localization not yet annotated |
Frequently Asked Questions
What is the expected molecular weight of recombinant ECE-1 on SDS-PAGE and Western blot?
ECE-1 (UniProt P42892) has a predicted molecular weight of ~87 kDa based on its 770-amino-acid sequence. Because this recombinant is produced in HEK293 cells, mammalian N-linked glycosylation shifts the apparent molecular weight on SDS-PAGE to approximately 100–110 kDa under denaturing, reducing conditions — consistent with what is observed for native ECE-1 in endothelial cell lysates. If you are running this as a positive control alongside RP-ECE1 antibody blots, load 20–50 ng per lane and expect a diffuse band in the 100–110 kDa region due to glycan heterogeneity.
Which isoform of ECE-1 does this recombinant correspond to, and does it include the transmembrane domain?
This recombinant corresponds to the ECE-1 isoform that retains the catalytically active extracellular metalloprotease domain. The full-length protein is a type II transmembrane zinc metalloprotease; the recombinant construct expresses the ectodomain sufficient for big endothelin-1 cleavage activity, removing the need for membrane solubilization in solution-phase assays. The zinc-binding HEXXH motif and the Trp21–Val22 scissile-bond specificity determinants are intact. If your experiment requires the native membrane topology, this soluble ectodomain form is the standard comparator used in kinetic and inhibitor-screening studies.
What substrate does ECE-1 cleave and how do I set up a fluorogenic activity assay with this recombinant?
ECE-1 (EC 3.4.24.71) cleaves the Trp21–Val22 bond of big endothelin-1 (big ET-1) to generate the 21-residue vasoactive peptide ET-1. For fluorogenic assays, a quenched fluorescent big ET-1 analogue (e.g., Mca-big ET-1 peptide substrates) is the standard choice. Run reactions in 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 5 mM CaCl2 at 37°C. A starting enzyme concentration of 1–5 nM recombinant ECE-1 with substrate concentrations spanning 1–100 µM allows reliable Km determination. Confirm linearity of signal with time before endpoint reads.
What buffer conditions are optimal for ECE-1 activity assays, and does the storage buffer interfere?
The storage buffer — 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol, 5 mM CaCl2 — is directly compatible with standard ECE-1 activity assays. Dilute the stock into the same buffer immediately before use to keep the glycerol contribution below 1% in the final assay volume, as higher glycerol concentrations can modestly suppress kcat. ECE-1 activity is zinc-dependent; avoid chelating agents such as EDTA or EGTA entirely. Phosphoramidon (10 µM) serves as a reliable positive inhibitor control for assay validation. pH 7.5 is optimal; activity drops noticeably below pH 6.5 or above pH 8.5.
How do I determine IC50 values for metalloprotease inhibitors using recombinant ECE-1?
Set up the inhibitor dose-response at a fixed ECE-1 concentration (2–5 nM) and a substrate concentration at or below the Km of big ET-1 (~10–20 µM for most fluorogenic analogues), which maximises sensitivity to competitive inhibitors. Pre-incubate enzyme with inhibitor for 15 minutes at 37°C before initiating the reaction with substrate. Phosphoramidon, a benchmark ECE-1 inhibitor with a reported IC50 in the low-nanomolar range, should anchor every plate as a reference compound. Use at least eight inhibitor concentrations spanning three log units and fit data to a four-parameter logistic model.
Can I use REC-ECE1 as a positive control for Western blot with the matched RP-ECE1 antibody?
Yes — this is one of the primary intended uses of REC-ECE1. The matched antibody RP-ECE1 (rabbit polyclonal; see /anti-ece-1-rabbit-polyclonal-antibody) was validated against HEK293-expressed ECE-1, so these two reagents are guaranteed compatible for Western blot. Load 20–50 ng of REC-ECE1 per lane alongside your cell lysate samples. The recombinant will run at ~100–110 kDa (glycosylated), providing a clean, reproducible reference band. This eliminates the common ambiguity of whether a faint or absent band in experimental lanes reflects low ECE-1 expression or antibody/transfer failure.
How much REC-ECE1 should I load per lane for a Western blot positive control, and what antibody dilution should I use with RP-ECE1?
Load 20–50 ng of REC-ECE1 per lane for a strong, non-saturating positive control band. For the matched RP-ECE1 rabbit polyclonal antibody, a primary dilution of 1:500–1:2,000 in 5% non-fat milk/TBST is a reliable starting point for standard ECL detection on PVDF membranes. Titrate to your specific chemiluminescence system — HRP-based detection with a 1:1,000 primary typically gives a clean band within a 1–5 minute exposure. Since both the recombinant and the antibody originate from the same program, no additional cross-reactivity qualification is needed before use.
How should I store and handle REC-ECE1 to preserve activity, and what is the recommended shelf life?
Store at -20°C in the single-use aliquots supplied. The 10% glycerol in the storage buffer provides cryoprotection; do not dilute to working concentration until immediately before use. Repeated freeze-thaw cycles measurably reduce metalloprotease activity — even two additional cycles can reduce recovered activity by 20–30% for zinc metalloproteases of this class. At -20°C in the original aliquots, activity is stable for at least 12 months. For short-term bench use (within one day), hold on ice; do not leave at room temperature for more than 30 minutes before initiating assays.
Validation imagery coming soon
Western blot validation figures for REC-ECE1 will be published here as they are produced in-house.
If you would like to see existing validation data for this antibody before publication, request a sample copy.